Treatment with Oral Diazepam for Prevention of Recurrence of Seizures following DTP and MMR Vaccination

Prophylactic treatment with oral diazepam to prevent recurrence of febrile seizures following triple vaccination with DTP and MMR: Randomize Controlled Trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210619051624N1

Enrollment

Registered

2021-09-29

Start date

2021-09-23

Completion date

Unknown

Last updated

2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Febrile seizures.

Interventions

Intervention 1: Intervention group: The group that will be treated with oral diazepam, and in addition to rectal Diazpam tube, Diazepam tablets are received from Sobhan Company at a dose of 1 mg per k

Eligibility

Sex/Gender

All

Age

6 Months to 6 Years

Inclusion criteria

Inclusion criteria: Children 6 months to 6 years old who have had a seizure following the vaccine There are no contraindications to vaccination.Patients with immunodeficiency, cancer, and patients taking corticosteroids are not included in the study.

Exclusion criteria

Exclusion criteria: Parental dissatisfaction Remove the vaccine from the patient's immunization schedule for any reason History of oral diazepam allergy Having contraindications for the MMR and DTP vaccines

Design outcomes

Primary

Measure	Time frame
Numbers of seizure. Timepoint: After vaccination. Method of measurement: By asking parents of patients.;Number of fevers. Timepoint: After vaccination. Method of measurement: By asking parents of patients.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Kordnezhadian

Ahvaz University of Medical Sciences

karami.9926@gmail.com+98 61 3444 9003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026